Search
Back

Pregabalin

CAS 148553-50-8
Pregabalin

General Information

Pregabalin is used to manage neuropathic pain (pain associated with nerve damage) and postherpetic neuralgia (a painful complication of shingles), and as adjunctive therapy for adult patients with partial onset seizures (epileptic fits starting in one specific part of the brain).


About the API

Technology Synthetic
Therapeutic category Epileptic
Available formulations Oral Liquid Oral Solid Oral Solid Long-Acting
Regulations
  • Japan DMF
  • Korea DMF
  • US DMF

Updates About Pregabalin

November 18, 2015
New DMF was approved in Korea.
November 15, 2016
New US DMF dated 11/2016 is available.
August 16, 2018
New Japan DMF is available.

The information detailed herein, including that with regard to active pharmaceutical ingredients , their use in treatments and possible mechanism(s) of action, was all obtained from public sources.

For more information on our services and products – including product suitability, intended uses and current availability – please contact Teva api Customer Service. CAS Registry Number is a Registered Trademark of the American Chemical Society. This webpage and any reference to the above product is to be read within the meaning and terms of the Legal Notes.